SPY315.85+1.47 0.47%
DIA259.50+2.26 0.88%
IXIC10,546.56-1.19 -0.01%

Canaccord Genuity Maintains Buy on Neurocrine Biosciences, Raises Price Target to $122

Canaccord Genuity maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and raises the price target from $120 to $122.

Benzinga · -

Canaccord Genuity maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and raises the price target from $120 to $122.